Clinical Trials on Immune Checkpoint Inhibitor in Austria

Total 3120 results

MacroGenics

Recruiting

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint Molecule

United States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
Flinders University
Flinders Medical Centre; Lyell McEwin Hospital

Recruiting

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors (MIICI)

Myocardial Injury | Myocarditis | Cardiotoxicity | Immune Checkpoint Inhibitors

Australia
Medical University of Graz

Completed

Probiotic Modulation of Intestinal Microbiota in Long-term Intake of Proton Pump Inhibitors

Patients on Long-term Proton Pump Inhibitor Therapy

Austria
Kaiser Franz Josef Hospital

Completed

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry (IDEAL-PCI)

Coronary Stent Implantation | Platelet Inhibition

Austria
University of Vienna

Completed

Yoga Practice, Stress and Cognitive Performance

Stress | Anxiety | Inhibition | Attentional Control Switching | Task Switching Between Modalities

Austria
Pharvaris Netherlands B.V.

Active, not recruiting

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (HAE CHAPTER-1)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

United States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
German Breast Group
Pfizer; AGO Study Group; Breast International Group; NSABP Foundation Inc

Completed

A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (PENELOPE-B)

Breast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG Score

United States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
Schülke & Mayr GmbH

Completed

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Austria, Germany
Shire

Terminated

Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema

ACE Inhibitor Induced Angioedema

United States
CSL Behring

Completed

Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.

Emphysema | Alpha 1-proteinase Inhibitor Deficiency

Australia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
ModernaTX, Inc.
AstraZeneca

Active, not recruiting

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or Lymphoma | Dose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma

United States, Israel, Australia
Novo Nordisk A/S

Active, not recruiting

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors (explorer7)

Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

Spain, Korea, Republic of, India, Australia, United Kingdom, Russian Federation, Poland, Ukraine, Thailand, Mexico, United States, Turkey, Japan, South Africa, Serbia, France, Croatia, Denmark, Algeria, Bulgaria, Malaysia, Portugal, Slovaki... and more
Medical University of Vienna

Recruiting

Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact

Allergy

Austria
University Hospital Inselspital, Berne
European Cardiovascular Research Center

Completed

GLOBAL LEADERS Adjudication Sub-Study (GLASSY)

Coronary Artery Disease | Platelet-aggregation Inhibitors

Bulgaria, Switzerland, Austria, Belgium, Germany, Italy, Netherlands, Poland, United Kingdom
Medical University of Vienna
Allergy Centre Vienna West

Unknown

Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1

Allergy

Austria
ALK-Abelló A/S

Completed

Assessment of Grazax® Treatment Compliance

Allergy

Austria
Krankenhaus Barmherzige Schwestern Linz
Verein zur Forschungsförderung der Krebshilfe OÖ; RECENDT GmbH; Johannes Kepler... and other collaborators

Recruiting

Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer (ROOCT)

Head and Neck Cancer | Radiotherapy

Austria
Medical University of Vienna

Recruiting

ALLoreactive T-Cell receptOr RePertoire in kidnEy tranSplantation (ALL-T-COPIES)

Transplant; Complication, Rejection | Renal Transplant Rejection | Immune Repertoire | Alloreactivity

Austria
Medical University of Vienna

Recruiting

Mold Allergy in Austria: Clinical Relevance of Alternaria Alternata and Related Species

Allergy | Fungal Allergy

Austria
Medical University of Vienna
Washington University School of Medicine

Completed

Perioperative Cardiac Troponin Levels in Healthy Adults

Extremity Orthopedic Surgery

Austria
Medical University of Vienna

Completed

A Pilot Study Investigating the Impact of Different IOL Designs on Subjective 2D and 3D Image Quality

Visual Acuity | Lenses | Intraocular Sensitivity

Austria
Novo Nordisk A/S

Completed

Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors (ONE)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

Saudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
Medical University of Vienna

Completed

A Pilot Study Simulating Multifocal Intraocular Lenses in Healthy Subjects

Visual Acuity | Lenses, Intraocular | Contrast Sensitivity

Austria
invIOs GmbH

Recruiting

PBMC-based Leukocyte Immunotherapy (PALINDROM)

Advanced Solid Tumor

Austria
Medical University of Graz

Completed

Vitamin D Supplementation and Regulatory FoxP3+ T Cells in the GUT

Immune Tolerance

Austria
Medical University of Vienna

Unknown

Evaluation of the Sphingolipid Metabolite S1P as a Novel Biomarker in Food Allergy

Food Allergy | Anaphylaxis

Austria
Medical University of Graz

Completed

The Effect of Antihypertensive Drugs on Severity of Anaphylaxis and Side-effects During Venom Immunotherapy (EADOAS)

Hymenoptera Venom Allergy | Antihypertensive Treatment

Austria
Medical University of Vienna

Completed

MTF Image Modifications

Visual Acuity | Contrast Sensitivity | Modulation Transfer Function

Austria
Novo Nordisk A/S

Active, not recruiting

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors (explorer8)

Haemophilia A Without Inhibitors | Haemophilia B Without Inhibitors

Spain, United States, Korea, Republic of, United Kingdom, Australia, Lithuania, France, Turkey, India, Estonia, Russian Federation, Ukraine, Mexico, Japan, South Africa, Serbia, Canada, Croatia, Algeria, Bosnia and Herzegovina, ... and more
Medical University of Graz

Recruiting

Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure (PREDICT)

Bee Venom Allergy

Austria
Medical University of Graz

Recruiting

Is the BAT Inhibition Able to Replace Sting Challenges? (BATIRS)

Vespid Venom Allergy

Austria
Medical University of Graz

Completed

Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans

Healthy Humans

Austria
Biomay AG
Medical University of Vienna

Completed

Skin Test Study of BM32

Hypersensitivity

Austria
Novo Nordisk A/S

Completed

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) (explorer™6)

Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B

France, United States, India, Mexico, United Kingdom, Netherlands, Sweden, Korea, Republic of, Spain, Switzerland, Serbia, Turkey, Bulgaria, Italy, Japan, Poland, South Africa, Croatia, Algeria, Australia, Bosnia and Herzegovina, ... and more
Novo Nordisk A/S

Completed

A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors (explorer™4)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

United States, Austria, Spain, Japan, Croatia, Italy, United Kingdom, Israel, Sweden, Ukraine, Malaysia, Greece, Denmark, Canada
Biomay AG

Completed

Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

Hypersensitivity

Austria
Medical University of Graz

Completed

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial (ENM-HS-001)

Diabetes, Type I

Austria
Tibotec Pharmaceuticals, Ireland

Completed

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

HIV

United Kingdom, Germany, Denmark, Belgium, Austria, Poland, Australia, Russian Federation
Medical University of Vienna

Completed

Effect of Intranasal Anti-IgE Antibodies on IgE Production

Allergy

Austria
Medical University of Vienna

Completed

Siderophore-profile in Allergic and Non-allergic Subjects

Healthy | Allergy | Allergic Sensitisation

Austria
Medical University of Vienna

Unknown

Endomicroscopy and Graft-versus-host Disease

Haematopoietic Stem Cell Transplantation

Austria
Medical University of Graz
European Commission

Completed

Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors (REACT4SENSOR)

Diabetes

Austria
Medical University of Vienna

Completed

Prevalence of Cutaneous Autoimmune Phenomena in HIV Infected Patients

HIV Infections | Autoimmune Diseases Affecting Skin

Austria
Celgene Corporation

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

Ireland, Spain, Australia, Austria, United Kingdom
Octapharma

Completed

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Immune Thrombocytopenic Purpura

Austria
Medical University of Vienna

Unknown

Long-term Follow-up of Subfoveal Neovascular AMD

Exudative Age-related Macular Degeneration

Austria
Arbeitsgemeinschaft medikamentoese Tumortherapie

Recruiting

AGMT Austrian Lymphoma Registry

Lymphoma

Austria
Medical University of Vienna

Completed

Extended Analysis for Leukemia/Lymphoma Treatment (EXALT)

Relapsed Hematologic Malignancy

Austria
Octapharma

Terminated

Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases

Immunologic Deficiency Syndromes

Austria
Hoffmann-La Roche

Completed

Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Austria

Clinical Trials on Immune Checkpoint Inhibitor in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations